ReactWise

ReactWise is developing an "AI copilot" to optimize chemical manufacturing processes for drug development, aiming to accelerate the process by up to 30x. Their AI models analyze thousands of reactions to provide efficient process recommendations, reducing the time and resources needed to bring new drugs to market.

Funding Round: Pre-Seed

Funding Amount: $3.4M

Date: 17-Mar-2025

Investors: Y Combinator, unnamed venture capitalists, angel investors

Markets: AI, Pharmaceuticals, Chemical, Medical, Pharmaceutical, Business/Productivity Software, Database Software

HQ: London, England, United Kingdom

Founded: 2024

Website: https://www.reactwise.com

LinkedIn: https://www.linkedin.com/company/reactwise

Twitter: https://twitter.com/ReactWise

Instagram:

Facebook: